Issue 3/2016
Content (12 Articles)
Current Opinion
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
Sunad Rangarajan, Morgan L. Locy, Tracy R. Luckhardt, Victor J. Thannickal
Open Access
Leading Article
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Lidia Bakota, Roland Brandt
Open Access
Therapy in Practice
What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion
R. Vellucci, G. Fanelli, R. Pannuti, C. Peruselli, S. Adamo, G. Alongi, F. Amato, L. Consoletti, L. Lamarca, S. Liguori, C. Lo Presti, A. Maione, S. Mameli, F. Marinangeli, S. Marulli, V. Minotti, D. Miotti, L. Montanari, G. Moruzzi, S. Palermo, M. Parolini, P. Poli, W. Tirelli, A. Valle, P. Romualdi
Review Article
Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy
Nick van Es, Suzanne M. Bleker, Ineke T. Wilts, Ettore Porreca, Marcello Di Nisio
Review Article
Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis
Roy A. Pleasants, Tiansheng Wang, Jinming Gao, Huilin Tang, James F. Donohue
Adis Drug Evaluation
Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
Hannah A. Blair, Gillian M. Keating
Adis Drug Evaluation
Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
Paul L. McCormack